Paper Details
- Home
- Paper Details
Cost-effectiveness of prostate cancer screening: a systematic review of decision-analytical models.
Author: CoastJoanna, DonovanJenny L, MartinRichard M, MohiuddinSyed, SangheraSabina
Original Abstract of the Article :
There is ongoing debate about the harms and benefits of a national prostate cancer screening programme. Several model-based cost-effectiveness analyses have been developed to determine whether the benefits of prostate cancer screening outweigh the costs and harms caused by over-detection and over-tr...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773135/
データ提供:米国国立医学図書館(NLM)
Prostate Cancer Screening: A Cost-Effectiveness Debate
The debate surrounding prostate cancer screening continues, with ongoing discussion about the potential benefits and risks associated with a national screening program. This systematic review examines the cost-effectiveness of prostate cancer screening, synthesizing data from various decision-analytic models to evaluate the balance between benefits and harms.
Navigating the Complexities of Prostate Cancer Screening
The review highlights the challenges in determining the cost-effectiveness of prostate cancer screening due to the varying approaches employed in different decision-analytic models. The authors emphasize the importance of considering the potential harms of over-detection and over-treatment, alongside the benefits of early detection and intervention. The review provides a valuable framework for understanding the complexities of prostate cancer screening and its associated costs and benefits.
Informed Decision-Making in Prostate Cancer Screening
This systematic review serves as a crucial resource for healthcare providers, policy makers, and individuals seeking information about prostate cancer screening. The review's analysis of the cost-effectiveness of screening, taking into account both benefits and harms, provides a foundation for informed decision-making. The review underscores the need for further research to refine screening strategies and optimize the balance between benefits and risks.
Dr.Camel's Conclusion
The decision to undergo prostate cancer screening can be as complex as navigating a desert with shifting sands. This systematic review offers a valuable compass, guiding us through the debate about the cost-effectiveness of screening. The review underscores the importance of considering both benefits and harms, emphasizing the need for a balanced approach to prostate cancer screening. Ultimately, informed decision-making, informed by both evidence and individual risk factors, is paramount in navigating this complex landscape.
Date :
- Date Completed 2018-08-07
- Date Revised 2018-12-02
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.